Incyte Corporation (INCY) News Headlines

▮ More

Date

Headline

9/12/2022 11:30:03 AM Incyte To Present At Morgan Stanley Healthcare Conference; Webcast At 12:30 PM ET

8/26/2022 10:16:14 AM Incyte : FDA Oks Pemazyre For Treatment Of Myeloid/lymphoid Neoplasms With FGFR1 Rearrangement

8/26/2022 10:02:40 AM Incyte : FDA Approves Pemazyre As Targeted Treatment For Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

8/2/2022 7:25:58 AM Incyte Q1 Results Top Estimates

8/2/2022 7:09:50 AM Incyte Q2 GAAP EPS $0.72; Non-GAAP EPS $1.01

8/2/2022 7:00:23 AM Incyte Q2 22 Earnings Conference Call At 8:00 AM ET

6/28/2022 3:17:30 AM Biotech Stocks Facing FDA Decision In July 2022

6/15/2022 6:55:15 AM Pre-market Movers: REV, ASTL, VNRX, VORB, GGR…

6/14/2022 10:00:59 AM Incyte To Present At Goldman Sachs Global Healthcare Conference; Webcast At 11:00 AM ET

6/14/2022 3:39:14 AM FDA Approves First Medicine Ever For Alopecia Areata

6/14/2022 1:47:24 AM FDA Approves Lilly's Olumiant As First Systemic Treatment For Alopecia

5/20/2022 8:29:07 AM Lilly : CHMP Issues Positive Opinion For Olumiant For Severe Alopecia Areata Treatment

5/20/2022 8:19:00 AM Lilly : CHMP Issues Positive Opinion For OLUMIANT For Treatment Of Adults With Severe Alopecia Areata

5/11/2022 7:04:22 AM Eli Lilly, Incyte Announce FDA Approval Of OLUMIANT For Hospitalized Patients With COVID-19

5/11/2022 6:51:49 AM Lilly And Incyte: FDA Approves OLUMIANT For Certain Hospitalized Patients With COVID-19

5/3/2022 8:12:32 AM Incyte Q1 Results Miss Estimates

5/3/2022 7:10:46 AM Incyte Q1 GAAP EPS $0.17; Non-GAAP EPS $0.55

5/3/2022 7:00:33 AM Incyte Q1 22 Earnings Conference Call At 8:00 AM ET

4/13/2022 8:41:56 AM Why BriaCell Therapeutics Is Rising In Pre-market?

3/22/2022 10:23:01 PM MorphoSys : Swissmedic Temporarily Approves Minjuvi - Lenalidomid Combination For DLBCL Treatment